Skip to main content
Erschienen in: Clinical Rheumatology 9/2021

19.01.2021 | Review Article

Pregnancy outcomes in women with ankylosing spondylitis: a scoping literature and methodological review

verfasst von: Abir Mokbel, Daeria O. Lawson, Forough Farrokhyar

Erschienen in: Clinical Rheumatology | Ausgabe 9/2021

Einloggen, um Zugang zu erhalten

Abstract

In this scoping review, we sought to summarize the types of outcomes collected in pregnant patients with ankylosing spondylitis (AS), and to identify some methodological limitations related to pregnancy research in these patients. A comprehensive search was done to identify relevant articles in MEDLINE and Embase. We included 21 studies assessing pregnancy outcomes in AS. Most studies reported disease flare during pregnancy, and few reported improved disease activity or stable disease. Disease flare occurred in 25–80% of patients during pregnancy and in 30–100% during the postpartum. There was no increased risk of pre-eclampsia across all studies. Based on two case-control studies, there was an increased risk for prematurity and small for gestational age in AS pregnancies, pooled odds ratio (95% confidence interval) 1.99 (1.30–3.05) and 2.41 (1.22–4.77), respectively. The etiologies of cesarean section were not related to joint issues from AS but were related to other causes like pre-eclampsia and prematurity. Some key methodological issues were related to the study design, selection of study participants, disease classification, choice of control participants, and outcome measures. Based on the current literature review, some key areas for future research should evaluate the disease state at conception, effects of pharmacological treatment for AS during pregnancy, and long-term outcomes of children born to women with AS. The use of pregnancy registers and validated measurement tools in pregnancy will help to improve the state and quality of evidence in this field.
Key Points
• Disease flare during pregnancy in patients with ankylosing spondylitis (AS) occurred in 25–80% of the cases in the various studies, and in 30–100% of the cases during the postpartum period.
• There was an increased risk for prematurity, and no increased risk of pre-eclampsia or small for gestational age. Etiologies of cesarean section were not related to the hip or sacroiliac joint affection of the disease but to other causes like pre-eclampsia and prematurity.
• This study provides a comprehensive overview of issues related to research on pregnant women with ankylosing spondylitis (AS). We addressed methodological issues related to the study design, selection of study participants, disease classification, control choice, assessment of outcomes measures, and statistical analysis.
• The use of pregnancy registers and validated disease activity measurement tools for pregnancy can enhance pregnancy research in women with AS.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
6.
Zurück zum Zitat Ostensen M, Husby G (1984) Pregnancy and rheumatic disease. A review of recent studies in rheumatoid arthritis and ankylosing spondylitis. Klin Wochenschr 62(19):891–895CrossRefPubMed Ostensen M, Husby G (1984) Pregnancy and rheumatic disease. A review of recent studies in rheumatoid arthritis and ankylosing spondylitis. Klin Wochenschr 62(19):891–895CrossRefPubMed
8.
Zurück zum Zitat Zhou Q, Bian XM, Liu JT (2012) Management of pregnancy with ankylosing spondylitis. Chin Med Sci J 27(1):46–49CrossRefPubMed Zhou Q, Bian XM, Liu JT (2012) Management of pregnancy with ankylosing spondylitis. Chin Med Sci J 27(1):46–49CrossRefPubMed
11.
Zurück zum Zitat Ostensen M, Romberg O, Husby G (1982) Ankylosing spondylitis and motherhood. Arthritis Rheum 25(2):140–143CrossRefPubMed Ostensen M, Romberg O, Husby G (1982) Ankylosing spondylitis and motherhood. Arthritis Rheum 25(2):140–143CrossRefPubMed
24.
Zurück zum Zitat Ostensen M, von Schoultz B, Husby G (1983) Comparison between serum alpha 2-pregnancy-associated globulin and activity of rheumatoid arthritis and ankylosing spondylitis during pregnancy. Scand J Rheumatol 12(3):315–318CrossRefPubMed Ostensen M, von Schoultz B, Husby G (1983) Comparison between serum alpha 2-pregnancy-associated globulin and activity of rheumatoid arthritis and ankylosing spondylitis during pregnancy. Scand J Rheumatol 12(3):315–318CrossRefPubMed
25.
Zurück zum Zitat Ostensen M (1984) The influence of pregnancy on blood parameters in patients with rheumatic disease. Scand J Rheumatol 13(3):203–208CrossRefPubMed Ostensen M (1984) The influence of pregnancy on blood parameters in patients with rheumatic disease. Scand J Rheumatol 13(3):203–208CrossRefPubMed
26.
Zurück zum Zitat Ostensen M, Ostensen H (1998) Ankylosing spondylitis--the female aspect. J Rheumatol 25(1):120–124PubMed Ostensen M, Ostensen H (1998) Ankylosing spondylitis--the female aspect. J Rheumatol 25(1):120–124PubMed
28.
Zurück zum Zitat Østensen M, Förger F, Nelson JL, Schuhmacher A, Hebisch G, Villiger PM (2005) Pregnancy in patients with rheumatic disease: anti-inflammatory cytokines increase in pregnancy and decrease post partum. Ann Rheum Dis 64(6):839–844CrossRefPubMed Østensen M, Förger F, Nelson JL, Schuhmacher A, Hebisch G, Villiger PM (2005) Pregnancy in patients with rheumatic disease: anti-inflammatory cytokines increase in pregnancy and decrease post partum. Ann Rheum Dis 64(6):839–844CrossRefPubMed
32.
36.
Zurück zum Zitat Wells GA, Tugwell P, O’Connell D, Welch V, Peterson J, Shea B, Losos M (2015) The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses Wells GA, Tugwell P, O’Connell D, Welch V, Peterson J, Shea B, Losos M (2015) The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses
38.
42.
Zurück zum Zitat Crisafulli F, Andreoli L, Gerardi MC, Fernandez AG, Nalli C, Filippini M, Gorla R, Taglietti M, Fredi M, Lazzaroni MG, Lojacono A, Zatti S, Franceschini F, Tincani A (2019) Disease course and outcomes during pregnancy in patients with axial spondiloarthritis: comparison between TNFi users and naive patients. Ann Rheum Dis 78(Supplement 2):878. https://doi.org/10.1136/annrheumdis-2019-eular.7705CrossRef Crisafulli F, Andreoli L, Gerardi MC, Fernandez AG, Nalli C, Filippini M, Gorla R, Taglietti M, Fredi M, Lazzaroni MG, Lojacono A, Zatti S, Franceschini F, Tincani A (2019) Disease course and outcomes during pregnancy in patients with axial spondiloarthritis: comparison between TNFi users and naive patients. Ann Rheum Dis 78(Supplement 2):878. https://​doi.​org/​10.​1136/​annrheumdis-2019-eular.​7705CrossRef
45.
Zurück zum Zitat Sammaritano LR, Bermas BL, Chakravarty EE, Chambers C, Clowse MEB, Lockshin MD, Marder W, Guyatt G, Branch DW, Buyon J, Christopher-Stine L, Crow-Hercher R, Cush J, Druzin M, Kavanaugh A, Laskin CA, Plante L, Salmon J, Simard J, Somers EC, Steen V, Tedeschi SK, Vinet E, White CW, Yazdany J, Barbhaiya M, Bettendorf B, Eudy A, Jayatilleke A, Shah AA, Sullivan N, Tarter LL, Birru Talabi M, Turgunbaev M, Turner A, D’Anci KE (2020) American College of Rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases. Arthritis Rheumatol 72:529–556. https://doi.org/10.1002/art.41191CrossRefPubMed Sammaritano LR, Bermas BL, Chakravarty EE, Chambers C, Clowse MEB, Lockshin MD, Marder W, Guyatt G, Branch DW, Buyon J, Christopher-Stine L, Crow-Hercher R, Cush J, Druzin M, Kavanaugh A, Laskin CA, Plante L, Salmon J, Simard J, Somers EC, Steen V, Tedeschi SK, Vinet E, White CW, Yazdany J, Barbhaiya M, Bettendorf B, Eudy A, Jayatilleke A, Shah AA, Sullivan N, Tarter LL, Birru Talabi M, Turgunbaev M, Turner A, D’Anci KE (2020) American College of Rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases. Arthritis Rheumatol 72:529–556. https://​doi.​org/​10.​1002/​art.​41191CrossRefPubMed
52.
Zurück zum Zitat Rudwaleit M, van der Heijde D, Landewé R, Listing J, Akkoc N, Brandt J, Braun J, Chou CT, Collantes-Estevez E, Dougados M, Huang F, Gu J, Khan MA, Kirazli Y, Maksymowych WP, Mielants H, Sørensen IJ, Ozgocmen S, Roussou E, Valle-Oñate R, Weber U, Wei J, Sieper J (2009) The development of Assessment of Spondyloarthritis International Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68(6):777–783. https://doi.org/10.1136/ard.2009.108233CrossRefPubMed Rudwaleit M, van der Heijde D, Landewé R, Listing J, Akkoc N, Brandt J, Braun J, Chou CT, Collantes-Estevez E, Dougados M, Huang F, Gu J, Khan MA, Kirazli Y, Maksymowych WP, Mielants H, Sørensen IJ, Ozgocmen S, Roussou E, Valle-Oñate R, Weber U, Wei J, Sieper J (2009) The development of Assessment of Spondyloarthritis International Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68(6):777–783. https://​doi.​org/​10.​1136/​ard.​2009.​108233CrossRefPubMed
57.
Zurück zum Zitat Warren RB, Reich K, Langley RG, Strober B, Gladman D, Deodhar A, Bachhuber T, Bao W, Altemeyer E, Hussain S, Safi J (2018) Secukinumab in pregnancy: outcomes in psoriasis, psoriatic arthritis and ankylosing spondylitis from the global safety database. Br J Dermatol 179(5):1205–1207. https://doi.org/10.1111/bjd.16901CrossRefPubMed Warren RB, Reich K, Langley RG, Strober B, Gladman D, Deodhar A, Bachhuber T, Bao W, Altemeyer E, Hussain S, Safi J (2018) Secukinumab in pregnancy: outcomes in psoriasis, psoriatic arthritis and ankylosing spondylitis from the global safety database. Br J Dermatol 179(5):1205–1207. https://​doi.​org/​10.​1111/​bjd.​16901CrossRefPubMed
59.
Zurück zum Zitat Meissner Y, Fischer-Betz R, Andreoli L, Costedoat-Chalumeau N, De Cock D, Dolhain R, Forger F, Goll D, Molto A, Ozdemir R, Raio L, Nelson-Piercy C, Rodriguez-Garcia SC, Sciascia S, Wallenius M, Zbinden A, Zink A, Strangfeld A (2019) Development of a standardized minimal core data set for pregnancy registers in rheumatology - results of a EULAR task force. Ann Rheum Dis 78(Supplement 2):246. https://doi.org/10.1136/annrheumdis-2019-eular.4021CrossRef Meissner Y, Fischer-Betz R, Andreoli L, Costedoat-Chalumeau N, De Cock D, Dolhain R, Forger F, Goll D, Molto A, Ozdemir R, Raio L, Nelson-Piercy C, Rodriguez-Garcia SC, Sciascia S, Wallenius M, Zbinden A, Zink A, Strangfeld A (2019) Development of a standardized minimal core data set for pregnancy registers in rheumatology - results of a EULAR task force. Ann Rheum Dis 78(Supplement 2):246. https://​doi.​org/​10.​1136/​annrheumdis-2019-eular.​4021CrossRef
60.
Zurück zum Zitat Meissner Y, Strangfeld A, Costedoat-Chalumeau N, Forger F, Molto A, Wallenius M, Fischer-Betz R (2018) Defining a standardized core data set for pregnancy registers in rheumatic diseases-an European approach. Arthritis Rheumatol 70(Supplement 9):2684–2685. https://doi.org/10.1002/art.40700CrossRef Meissner Y, Strangfeld A, Costedoat-Chalumeau N, Forger F, Molto A, Wallenius M, Fischer-Betz R (2018) Defining a standardized core data set for pregnancy registers in rheumatic diseases-an European approach. Arthritis Rheumatol 70(Supplement 9):2684–2685. https://​doi.​org/​10.​1002/​art.​40700CrossRef
61.
62.
Zurück zum Zitat Andreoli L, Gerardi MC, Fernandes M, Bortoluzzi A, Bellando-Randone S, Brucato A, Caporali R, Chighizola CB, Chimenti MS, Conigliaro P, Cutolo M, Cutro MS, D’Angelo S, Doria A, Elefante E, Fredi M, Galeazzi M, Gerosa M, Govoni M, Iuliano A, Larosa M, Lazzaroni MG, Matucci-Cerinic M, Meroni M, Meroni PL, Mosca M, Patanè M, Pazzola G, Pendolino M, Perricone R, Ramoni V, Salvarani C, Sebastiani GD, Selmi C, Spinelli FR, Valesini G, Scirè CA, Tincani A (2019) Disease activity assessment of rheumatic diseases during pregnancy: a comprehensive review of indices used in clinical studies. Autoimmun Rev 18(2):164–176. https://doi.org/10.1016/j.autrev.2018.08.008CrossRefPubMed Andreoli L, Gerardi MC, Fernandes M, Bortoluzzi A, Bellando-Randone S, Brucato A, Caporali R, Chighizola CB, Chimenti MS, Conigliaro P, Cutolo M, Cutro MS, D’Angelo S, Doria A, Elefante E, Fredi M, Galeazzi M, Gerosa M, Govoni M, Iuliano A, Larosa M, Lazzaroni MG, Matucci-Cerinic M, Meroni M, Meroni PL, Mosca M, Patanè M, Pazzola G, Pendolino M, Perricone R, Ramoni V, Salvarani C, Sebastiani GD, Selmi C, Spinelli FR, Valesini G, Scirè CA, Tincani A (2019) Disease activity assessment of rheumatic diseases during pregnancy: a comprehensive review of indices used in clinical studies. Autoimmun Rev 18(2):164–176. https://​doi.​org/​10.​1016/​j.​autrev.​2018.​08.​008CrossRefPubMed
Metadaten
Titel
Pregnancy outcomes in women with ankylosing spondylitis: a scoping literature and methodological review
verfasst von
Abir Mokbel
Daeria O. Lawson
Forough Farrokhyar
Publikationsdatum
19.01.2021
Verlag
Springer International Publishing
Erschienen in
Clinical Rheumatology / Ausgabe 9/2021
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-021-05588-9

Weitere Artikel der Ausgabe 9/2021

Clinical Rheumatology 9/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

03.06.2024 NSCLC Nachrichten

Wie stark Menschen mit fortgeschrittenem NSCLC von einer Therapie mit Immun-Checkpoint-Hemmern profitieren, hängt offenbar auch davon ab, wie sehr die Diagnose ihre psychische Verfassung erschüttert

Antikörper mobilisiert Neutrophile gegen Krebs

03.06.2024 Onkologische Immuntherapie Nachrichten

Ein bispezifischer Antikörper formiert gezielt eine Armee neutrophiler Granulozyten gegen Krebszellen. An den Antikörper gekoppeltes TNF-alpha soll die Zellen zudem tief in solide Tumoren hineinführen.

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.